We present the results of a double-blind randomized controlled trial ( dbRCT ) on the pharmacokinetic , clinical , and molecular activity of dietary supplements containing lycopene , selenium , and green tea catechins ( GTCs ) in men with multifocal high grade prostatic intraepithelial neoplasia ( mHGPIN ) and/or atypical small acinar proliferation ( ASAP ) .